ARCHIVES

Fisher Address Gap Between Clinicians Investigators, A Threat To Patient Welfare

This article is from The Cancer Letter archive.

Vol. 19 No. 22 | May 28, 1993

Download PDF Visit The Full Archive

Related Articles

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

May 25, 2001

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

NIH Expands Minority Biomedical Research Training

July 11, 1975

Southern Screening Contract Now at $2 Mil. Year For Five Year

June 7, 1974

Centers, Control to Be In New Division; Upton Moves Fink Up; Terry Acting Director Of DCCR

May 4, 1979

NCI Programs: NCI Drug Screening To Take More Targeted Approach; BSA Okays Plan To Support New MA Contracts

April 3, 1998